$VSEE

VSEE HEALTH, INC. (VSEE): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

VSEE HEALTH, INC. (VSEE) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers On August 27, 2026, Scott Metzger resigned, effective immediately, as a member of the Board of Directors (the “Board”) of VSe

Original reporting
Published Aug 31, 2026, 8:10 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 31, 2026, 8:14 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$VSEE
Neutral
high confidence
Mentioned
$VSEE
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$VSEENeutralLow
01

Why it matters

The filing provides the first public notice of the departure, a standard corporate governance update.

02

Market read

Minor corporate action with limited trading impact; primarily of interest to current shareholders and governance‑focused investors.

03

What to watch

Potential upcoming board re‑appointments or strategic shifts not disclosed yet.

Relevance 6/10Novelty 5/10Timing: post‑market Aug 31, 2026

Background

VSEE Health, Inc. filed a Form 8‑K reporting a board member's resignation.

Company-level read

Ticker impact

$VSEENeutralHigh confidence
Context

Scott Metzger resigned from the Board and Compensation Committee on Aug 27, 2026, disclosed in an 8‑K filing.

Expected impact

minimal short‑term price movement

Evidence & confidence

Director departures are routine corporate actions; market typically reacts modestly unless tied to controversy.

Market effects

None significant for the broader health‑tech sector.

No regional effect beyond VSEE shareholders.

Limited to investors tracking corporate governance updates.

Counterpoint

If the resignation signals deeper governance issues, the stock could face pressure.

Key entities

  • VSEE Health, Inc.

    Public health‑technology company (ticker VSEE).

  • Scott Metzger

    Resigning board member and Compensation Committee member.

Related articles

$VSEEMedAI 8/10

VSee Health Signs LOI for Healthcare Platform Acquisition Target With Over $35 Million in Annualized Revenue

VSee Health (NASDAQ:VSEE) said it signed a non-binding letter of intent to acquire healthcare technology and operating assets for a vertically integrated healthcare commerce platform. VSee estimates the deal value at about $42 million, with target annualized revenue over $35 million and about $7 million EBITDA, unaudited. Closing depends on due diligence, definitive agreements, and approvals.

$VSEEMedAI 8/10

VSee Health to Acquire $35M Healthcare Commerce Platform

VSee Health, Inc. signed a non-binding LOI to acquire healthcare technology and operating assets valued at about $42 million. The target supports a clinic-based wellness commerce platform with an unaudited annual revenue run rate over $35 million and about $7 million in EBITDA. VSee says it would integrate ordering and payment workflows into its API virtual care platform, subject to due diligence and approvals.

$VSEEMed

VSee Health: VSee Enters into Letter of Intent to Acquire Vertically Integrated Healthcare Commerce Platform - Acquisition, Valued at $42Million, Would Add over $35Million in Annualized Revenue and Mo

VSee Health (NASDAQ:VSEE) said it entered a non-binding letter of intent to acquire certain healthcare technology and operating assets for a vertically integrated healthcare commerce platform. The target assets have an unaudited run rate above $35 million and EBITDA around $7 million. VSee expects a quick close without initial shareholder dilution, subject to due diligence and definitive agreements.

$VSEEMed

VSEE HEALTH, INC. (VSEE): Completion of Acquisition or Disposition of Assets

VSEE HEALTH, INC. (VSEE) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. EX-99.1 3 vseeex99-1.htm EXHIBIT 99.1 Exhibit 99.1 VSEE HEALTH, INC. UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL STATEMENTS On May 31, 2026, VSee Health, Inc., a Delaware corporation (the “Company”) entered into a Stock Purchase Agreement (the “Purchase Agreement”) with

$PBFHighAI 9/10

PBF Energy Announces Pricing of $500 Million of 0% Exchangeable Notes due 2032

PBF Energy's subsidiary priced $500M in 0% exchangeable notes due 2032, with an option for $50M more. Notes are senior, unsecured, and guaranteed by certain subsidiaries. They can be exchanged for cash, stock, or a mix, with an initial exchange rate of 10.3306 shares per $1,000. The offering is expected to close September 17, 2026, with net proceeds estimated at $485M ($533.6M if the option is fully exercised).